NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+10.44%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.19B
AUM Growth
+$1.19B
(+19%)
Cap. Flow
+$55.1M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
45.75%
Holding
138
New
15
Increased
34
Reduced
25
Closed
7
Top Buys
| 1 |
Titan Machinery
TITN
|
$22.6M |
| 2 |
Fulcrum Therapeutics
FULC
|
$17.1M |
| 3 |
The Bancorp
TBBK
|
$13.4M |
| 4 |
PWSC
PowerSchool Holdings, Inc.
PWSC
|
$13.3M |
| 5 |
BlackSky Technology
BKSY
|
$11.6M |
Top Sells
| 1 |
Pathward Financial
CASH
|
$18.3M |
| 2 |
Bioventus
BVS
|
$11.8M |
| 3 |
IMAX
IMAX
|
$10.7M |
| 4 |
Instil Bio
TIL
|
$7.2M |
| 5 |
Establishment Labs
ESTA
|
$6.65M |
Sector Composition
| 1 | Healthcare | 68.55% |
| 2 | Consumer Discretionary | 10.79% |
| 3 | Communication Services | 5.34% |
| 4 | Financials | 5.01% |
| 5 | Industrials | 4.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Achieve Life Sciences
ACHV
$152M
| $3.1M | 0.16% | 654,000 | – | – |
|
77
DarioHealth
DRIO
$22.8M
| $2.8M | 0.14% | 2,503,312 +111,987 | +5% | +$125K |
|
78
Milestone Pharmaceuticals
MIST
$156M
| $2.66M | 0.13% | 1,750,000 | – | – |
|
79
AYTU BioPharma
AYTU
$21.1M
| $2.55M | 0.13% | 1,086,812 | – | – |
|
80
Surrozen
SRZN
$104M
| $2.24M | 0.11% | 187,206 | – | – |
|
81
MediaAlpha
MAX
$596M
| $2.24M | 0.11% | 123,564 | – | – |
|
82
Fossil Group
FOSL
$165M
| $2.23M | 0.11% | 1,905,278 | – | – |
|
83
SPDR S&P Biotech ETF
XBI
$5.07B
| $2.14M | 0.11% | 21,646 -723 | -3% | -$71.4K |
|
84
enVVeno Medical
NVNO
$15.4M
| $2.01M | 0.1% | 596,917 +119,062 | +25% | +$400K |
|
85
Scully Royalty
SRL
$78.2M
| $1.91M | 0.1% | 239,197 | – | – |
|
86
Neurogene
NGNE
$264M
| $1.77M | 0.09% | 42,279 -30,000 | -42% | -$1.26M |
|
87
BiomX
PHGE
$14.3M
| $1.77M | 0.09% | +1,730,600 | New | +$1.77M |
|
88
Talphera
TLPH
$11.1M
| $1.71M | 0.09% | 1,992,519 | – | – |
|
|
RNTX
89
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $1.64M | 0.08% | 464,367 | – | – |
|
90
SPAR Group
SGRP
$28.2M
| $1.62M | 0.08% | 662,028 | – | – |
|
91
Eledon Pharmaceuticals
ELDN
$155M
| $1.49M | 0.08% | 600,000 | – | – |
|
|
92
Instil Bio
TIL
$182M
| $1.36M | 0.07% | 20,276 -107,016 | -84% | -$7.2M |
|
93
Altisource Portfolio Solutions
ASPS
$126M
| $1.31M | 0.07% | 1,091,009 | – | – |
|
|
CMPS
94
Compass Pathways
CMPS
$424M
| $1.26M | 0.06% | +200,000 | New | +$1.26M |
|
95
Unicycive Therapeutics
UNCY
$74M
| $1.15M | 0.06% | 2,820,358 | – | – |
|
96
Strata Skin Sciences
SSKN
$9.93M
| $1.11M | 0.06% | 403,917 +100,000 | +33% | +$275K |
|
97
Anebulo Pharmaceuticals
ANEB
$103M
| $986K | 0.05% | 511,073 | – | – |
|
|
OKUR
98
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $931K | 0.05% | 547,804 | – | – |
|
99
Lazydays
GORV
$11M
| $827K | 0.04% | 551,135 +51,135 | +10% | +$76.7K |
|
100
Perfect Corp
PERF
$209M
| $805K | 0.04% | 419,133 | – | – |
|